BEGIN:VCALENDAR VERSION:2.0 PRODID:-//ChamberMaster//Event Calendar 2.0//EN METHOD:PUBLISH X-PUBLISHED-TTL:P3D REFRESH-INTERVAL:P3D CALSCALE:GREGORIAN BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=+2SU DTSTART:20070101T000000 TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:Eastern Daylight Time END:DAYLIGHT BEGIN:STANDARD RRULE:FREQ=YEARLY;BYMONTH=11;BYDAY=+1SU DTSTART:99991231T000000 TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:Eastern Standard Time END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20200630T100000 DTEND;TZID=America/New_York:20200630T110000 X-MICROSOFT-CDO-ALLDAYEVENT:FALSE SUMMARY:Increasing Testing Capacity for COVID-19 With Sherlock CRISPR-Based Diagnostics DESCRIPTION:CRISPR-based diagnostic methods are poised to have a significant impact on global health\, and now\, with the first FDA-emergency authorized use of CRISPR technology\, this impact is being brought directly to the fight against the global COVID-19 pandemic. Join us to learn more about how Sherlock Biosciences has been driving CRISPR innovation and how that mission\, with IDT's support\, has led to the Sherlock CRISPR SARS-CoV-2 kit. Our speakers will provide an overview of SHERLOCK CRISPR technology and how it has been adapted for specific and sensitive detection of SARS-CoV-2 to increase testing capacity. Objectives: Describe the basics of how the SHERLOCK CRISPR-based diagnostic tool works Overview of the Sherlock CRISPR SARS-CoV-2 kit and performance Understand the benefits of the Sherlock CRISPR SARS-CoV-2 kit and how it can help your lab increase testing capacity A live Q&A session will follow the presentations\, offering you a chance to pose questions.Learn more X-ALT-DESC;FMTTYPE=text/html:

CRISPR-based diagnostic methods are poised to have a significant impact on global health\, and now\, with the first FDA-emergency authorized use of CRISPR technology\, this impact is being brought directly to the fight against the global COVID-19 pandemic. Join us to learn more about how Sherlock Biosciences has been driving CRISPR innovation and how that mission\, with IDT'\;s support\, has led to the Sherlock&trade\; CRISPR SARS-CoV-2 kit. Our speakers will provide an overview of SHERLOCK CRISPR technology and how it has been adapted for specific and sensitive detection of SARS-CoV-2 to increase testing capacity. \;

Objectives: Describe the basics of how the SHERLOCK CRISPR-based diagnostic tool works \;

Overview of the Sherlock&trade\; CRISPR SARS-CoV-2 kit and performance

 \;Understand the benefits of the Sherlock CRISPR SARS-CoV-2 kit and how it can help your lab increase testing capacity A live Q&\;A session will follow the presentations\, offering you a chance to pose questions.

Learn more

LOCATION: UID:e.1244.200232 SEQUENCE:3 DTSTAMP:20200815T141932Z URL:https://business.massmedic.com/events/Details/increasing-testing-capacity-for-covid-19-with-sherlock-crispr-based-diagnostics-219753?sourceTypeId=Hub END:VEVENT END:VCALENDAR